Ruilin Pharma

Shenzhen Ruilin was founded in 1996 and is headquartered in Shenzhen, China. It is a comprehensive pharmaceutical marketing company mainly engaged in the promotion of clinical prescription drugs, medical devices, and consumables. It handles about 30 products, covering therapeutic areas such as ophthalmology, pain management, orthopedics, otolaryngology, and gastroenterology. By the beginning of 2016, Ruilin had established 34 academic liaison offices across the country, forming a nationwide professional academic promotion network, with more than 300 employees, annual sales of about 1 billion yuan, and per capita sales exceeding 3 million yuan.
Shenzhen Ruilin has under it Shenzhen Ruilin Pharmaceutical Co., Ltd., Shenzhen Ruilin Medical Devices Co., Ltd., and Shenzhen Mingsai Ruilin Pharmaceutical Co., Ltd., and has successively established partnerships with companies such as Japan's Senju Pharmaceutical, Japan's HOYA, Germany's Ursapharm, South Korea's LG, Japan's Nihon Kohden, Hubei Keyi, Dandong Yichuang, Finland's Icare, Germany's Boehringer Ingelheim, and the United States' Anika.
Shenzhen Ruilin is dedicated to providing high-quality products and professional pharmaceutical knowledge to doctors and patients. While maintaining steady growth in the field of specialized sales, it is also committed to the research and development of new drugs. It has obtained 1 clinical approval for a Class I new drug, 1 Class III new drug certificate, and has 3 other Class III new drug projects under research. Among them, the invention patent for a Class I new drug has been authorized by the State Intellectual Property Office, and an international PCT application has also been filed and entered the US application stage.
While operating steadily, Ruilin also joined hands with the Shenzhen Lions Club and the Ophthalmology Branch of the Chinese Medical Association to jointly establish the "Ruilin Ophthalmology Clinical Assistance (Lions) Fund," contributing 1 million yuan annually for ophthalmic clinical assistance to help impoverished patients with eye diseases regain sight and escape disability.
Ruilin advocates a "total rewards system." Employees can not only receive highly competitive compensation at or above the 75th percentile in the industry, but also enjoy a series of quality benefits such as localized social insurance and housing fund contributions, holiday greeting gifts, paid annual leave, annual travel, long-service overseas trips, and free shuttle buses. At the same time, the company actively provides employees with various internal and external training opportunities, supports and encourages internal promotion, and under a corporate culture of respect and care, colleagues and superiors and subordinates collaborate as equals, jointly building Ruilin into an employer with high cohesion and strong employee belonging.
Shenzhen Ruilin always strives to grow into a good company respected and trusted by employees, customers, and partners, insists on enhancing the value of the company and its employees, and contributes to human health and development.

For more details, please follow Ruilin's official website:

Shenzhen Ruilin looks forward to your joining!